Over the last 20 years, the NovaSure system has built a trusted legacy in GEA. The NovaSure device first received FDA approval in 2001, and by 2018 the NovaSure procedure had been used to treat over 3 ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, will launch the NovaSure® V5 global endometrial ablation (GEA) device at the American Association ...

“Since its launch over 20 years ago, we have constantly listened to our customers’ feedback, which has driven continuous design improvements for NovaSure,” said Jan Verstreken, Group President, ...

Over the last 20 years, the NovaSure system has built a trusted legacy in GEA. The NovaSure device first received FDA approval in 2001, and by 2018 the NovaSure procedure had been used to treat over 3 ...

MARLBOROUGH, Mass. — Hologic Inc. (Nasdaq: HOLX), a global leader in women’s health, has announced approval of the NovaSure ® V5 global endometrial ablation (GEA) device in Canada and Europe. This ...

NovaSure V5 has a cervical seal, featuring EndoForm technology, designed to increase the sealing surface and accommodate a range of cervical canals and anatomical variability. The NovaSure device ...

Hologic, one of the few companies to emerge from the pandemic stronger than it was before, has scored regulatory approvals in Canada and Europe for an updated version of its NovaSure V5 endometrial ...

MARLBOROUGH, Massachusetts, Nov. 14, 2016 /PRNewswire/ -- Hologic, Inc. (Nasdaq: HOLX) today announced the launch of its next-generation NovaSure ® 6mm global endometrial ablation (GEA) system, the ...

Hologic Inc. (Nasdaq: HOLX), a global leader in women's health, has announced approval of the NovaSure V5 global endometrial ablation (GEA) device in Canada and Europe. This innovative new version ...

3. The NovaSure disposable device tip nominal diameter: 7.5 mm. 4. The NovaSure disposable device overall dimensions: 19" x 6" x 12" (48.3 cm x 15.2 cm x 5 cm). 5. The NovaSure disposable device has a ...